Literature DB >> 1625863

Epidemiology, pathogenesis, and genetics of acoustic tumors.

M J Lanser1, S A Sussman, K Frazer.   

Abstract

This article reviews the epidemiology of both unilateral and bilateral (NF-2) acoustic tumors. The growth rate of acoustic tumors is examined from a clinical, radiographic, and laboratory perspective. The anatomic, histologic, and biochemical considerations as well as the influences of sex hormones on acoustic tumor formation are reviewed. Also presented are an update on the laboratory search for the NF-2 gene on chromosome 22 and recently identified DNA markers. Predictions are made concerning the potential future applications of genetic testing for prenatal or presymptomatic diagnosis of the disease that causes bilateral acoustic tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625863

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  18 in total

1.  Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.

Authors:  Andrew K Patel; Thomas H Alexander; Ali Andalibi; Allen F Ryan; Joni K Doherty
Journal:  Laryngoscope       Date:  2008-08       Impact factor: 3.325

2.  Malignant vestibular schwannoma.

Authors:  B Gruber; L Petchenik; M Williams; C Thomas; M G Luken
Journal:  Skull Base Surg       Date:  1994

3.  Baha implant as a hearing solution for single-sided deafness after retrosigmoid approach for the vestibular schwannoma: audiological results.

Authors:  Jan Bouček; Jan Vokřál; Libor Černý; Martin Chovanec; Michal Zábrodský; Eduard Zvěřina; Jan Betka; Jiří Skřivan
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-16       Impact factor: 2.503

4.  Baha implant as a hearing solution for single-sided deafness after retrosigmoid approach for the vestibular schwannoma: surgical results.

Authors:  Jan Boucek; Jan Vokral; Libor Cerny; Martin Chovanec; Jiří Skrivan; Eduard Zverina; Jan Betka; Michal Zabrodsky
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-14       Impact factor: 2.503

5.  Sociodemographic factors and vestibular schwannoma: a Danish nationwide cohort study.

Authors:  Joachim Schüz; Marianne Steding-Jessen; Søren Hansen; Sven-Eric Stangerup; Per Cayé-Thomasen; Christoffer Johansen
Journal:  Neuro Oncol       Date:  2010-11-10       Impact factor: 12.300

6.  Conservative management of acoustic neuroma.

Authors:  Abdulrahman Al Sanosi; Paul A Fagan; Nigel D W Biggs
Journal:  Skull Base       Date:  2006-05

7.  Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.

Authors:  Karo Tanaka; Ascia Eskin; Fabrice Chareyre; Walter J Jessen; Jan Manent; Michiko Niwa-Kawakita; Ruihong Chen; Cory H White; Jeremie Vitte; Zahara M Jaffer; Stanley F Nelson; Allan E Rubenstein; Marco Giovannini
Journal:  Clin Cancer Res       Date:  2013-05-28       Impact factor: 12.531

8.  Radiotherapy for vestibular schwannoma: Review of recent literature results.

Authors:  Giuseppina Apicella; Marina Paolini; Letizia Deantonio; Laura Masini; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-28

9.  Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas.

Authors:  B Ozgen; B Oguz; A Dolgun
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

Review 10.  The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature.

Authors:  Mark C Dougherty; Seiji B Shibata; Marlan R Hansen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.